These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23378990)

  • 1. [Demyelinating process in systematic rheumatoid diseases (review)].
    Pizova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):64-72. PubMed ID: 23378990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demyelination in rheumatic diseases.
    Theodoridou A; Settas L
    Postgrad Med J; 2008 Mar; 84(989):127-32. PubMed ID: 18372483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
    Kim SS; Richman DP; Johnson WO; Hald JK; Agius MA
    Mult Scler; 2014 Jan; 20(1):57-63. PubMed ID: 23736535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-MS autoimmune demyelination.
    Cikes N; Bosnic D; Sentic M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):905-12. PubMed ID: 18928881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?
    Ferreira S; D'Cruz DP; Hughes GR
    Rheumatology (Oxford); 2005 Apr; 44(4):434-42. PubMed ID: 15644391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of multiple sclerosis and autoimmune rheumatic diseases].
    Brola W; Fudala M; Kasprzyk M; Opara J
    Wiad Lek; 2013; 66(2 Pt 2):164-70. PubMed ID: 25775811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 8. Demyelination in rheumatic diseases.
    Theodoridou A; Settas L
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):290-5. PubMed ID: 16484634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: of syndromes and interfaces.
    Ehrlich GE
    Rheumatology; 1973; 4(0):1-12. PubMed ID: 4151988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Internal medicine and neurological diseases: progress in diagnosis and treatment topics: X. Neurological disorders in connective tissue disease].
    Tomizawa Y; Yokoyama K; Hattori N
    Nihon Naika Gakkai Zasshi; 2012 Aug; 101(8):2242-8. PubMed ID: 22973697
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular manifestations of systemic inflammatory diseases.
    Mohsenin A; Huang JJ
    Conn Med; 2012 Oct; 76(9):533-44. PubMed ID: 23155672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of peripheral arthropathies (author's transl)].
    Sauden Y
    Radiol Clin Biol; 1974; 43(4):283-91. PubMed ID: 4135107
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.
    Marinho A; Delgado Alves J; Fortuna J; Faria R; Almeida I; Alves G; Araújo Correia J; Campar A; Brandão M; Crespo J; Marado D; Matos-Costa J; Oliveira S; Salvador F; Santos L; Silva F; Fernandes M; Vasconcelos C
    Front Immunol; 2023; 14():1117699. PubMed ID: 37138867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Sjögren's syndrome and multiple sclerosis: similarity and differences].
    Pizova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):69-74. PubMed ID: 22677682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Big 3.
    Hughes G
    Lupus; 2018 Oct; 27(1_suppl):4-7. PubMed ID: 30452319
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
    de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
    J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical heterogeneity of systemic lupus erythematosus].
    Mazepa MA
    Lik Sprava; 1997; (3):25-30. PubMed ID: 9377347
    [No Abstract]   [Full Text] [Related]  

  • 20. Different criteria for different purposes.
    Edwards JC; Snaith ML
    J Rheumatol; 1988 Apr; 15(4):537-8. PubMed ID: 3260950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.